Quinolinyl-pyrrolopyrazoles

Details for Australian Patent Application No. 2003291643 (hide)

Owner Eli Lilly and Company

Inventors Yingling, Jonathan Michael; Beight, Douglas Wade; Sawyer, Jason Scott

Agent Spruson & Ferguson

Pub. Number AU-B-2003291643

PCT Number PCT/US2003/0327

PCT Pub. Number WO2004/048382

Priority 60/428,893 22.11.02 US

Filing date 10 November 2003

Wipo publication date 18 June 2004

Acceptance publication date 13 May 2010

International Classifications

C07D 487/04 (2006.01) Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups

A61K 31/4709 (2006.01) - Non-condensed quinolines containing further heterocyclic rings

A61P 35/00 (2006.01) Antineoplastic agents

Event Publications

8 April 2004 Complete Application Filed

  Priority application(s): 60/428,893 22.11.02 US

22 July 2004 Application Open to Public Inspection

  Published as AU-B-2003291643

13 May 2010 Application Accepted

  Published as AU-B-2003291643

9 September 2010 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2003291644-SIGNAL QUALITY MONITORING AND CONTROL FOR A MEDICAL DEVICE SYSTEM

2003291642-NOVEL PYRAZOLOAZEPINE COMPOUNDS AS PHARMACEUTICAL AGENTS